A discussion on the link between LVEF, nT-proBNP, and cardiac remodeling in predicting disease progression. Scott D. Solomon, MD: It’s important to remember that ejection fraction and natriuretic ...

June 18, 2009 (St Paul, Minnesota) — Plasma levels of N-terminal fragment of B-type natriuretic peptide (NT-proBNP) were significantly increased in association with asymptomatic LV systolic or ...

Measuring N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels preoperatively among patients scheduled to undergo inpatient noncardiac surgery can strongly predict the risk of major cardiac ...

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...

Zomedica launches two canine assays for TRUFORMA, including NT-proBNP for heart disease and progesterone for breeding. The assays provide reference lab-level accuracy in-clinic, enhancing diagnostics ...

NT-proBNP testing should become compulsory for referring patients to specialist heart failure services to improve diagnosis of the condition in primary care, an expert report has said. The Alliance ...

RARITAN, N.J. -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced the CE Mark of an enhanced version of its VITROS® NT-proBNP II assay, part of Ortho's expansive cardiac ...

Dallas, TX - The addition of natriuretic peptide testing to the traditional clinical evaluation of patients with dyspnea of suspected cardiac origin cut the duration of emergency-department visits by ...

At this year's congress of the American Heart Association (AHA) in Chicago, November 13-17, new data on the use of NT-proBNP to guide heart failure therapy was presented by study investigators from ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Among older adults with type 2 diabetes and chronic HF, treatment with the SGLT2 inhibitor ...